How a Patient-Support Program Increased Therapy Participation 20%, Upped Sales

by Kimberly Smith
Case study published on 1/29/2008

Tracleer won approval in 2001 as the first oral treatment for pulmonary arterial hypertension, an illness difficult for patients to grasp. Tracleer helps patients control the symptoms, but it has drawbacks. Faced with high patient-dropout rates early on in treatment, the drug's maker needed to change patient perceptions.